ConductScience.org, home
F11R: F11 receptor
API referenceFor AI assistants

Gene · 50848

Papers3,726

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 3,726

Download this page as JSON
TitleJournalYearPMIDFound bySource
Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis.Int Immunopharmacol202642826447PubTator, text miningPubMed
Brain endothelial homeostasis in psychiatric disorders: mechanisms, evidence, and translational opportunities.Front Cell Neurosci202642819782PubTator, text miningPubMed
Intestinal Epithelial-Protective Effects of Leuconostoc mesenteroides H40 in LPS-Stimulated HT-29 Cells.J Microbiol Biotechnol202642770193PubTator, text miningPubMed
Astragaloside IV ameliorates DSS-induced intestinal epithelial barrier dysfunction associated with modulation of tight junction proteins and MLCK/p-MLC and MyD88/TRAF6 signaling pathways.Front Pharmacol202642698578PubTator, text miningPubMed
Identification of a novel high-prevalence red blood cell antigen on junctional adhesion molecule-A defines a new blood group system.Vox Sang202642637667PubTator, text miningPubMed
F11 Receptor/Junctional Adhesion Molecule-A: a novel therapeutic target in breast cancer.Biochimie202642562075PubTator, text miningPubMed
Multi-Omics Integration Reveals That SN-011 Targets JUNB to Upregulate ADGRE5 and Restore Vascular Endothelial Cell Communication in Ischemic Stroke.Chem Biol Drug Des202642549987PubTator, text miningPubMed
Proteomic profiling of single extracellular vesicles reveals association of CD31+ EV subpopulation with immune dysregulation in people living with HIV.Front Immunol202642483197PubTator, text miningPubMed
Mesenchymal stem cells receive adaptive islet-derived miR-151-containing sEVs to promote β cell compensation in obesity.Sci Adv202642467765PubTator, text miningPubMed
12-HHT is associated with epithelial barrier enhancement and reduced inflammatory responses in colon organoids of normoganglionosis in Hirschsprung's disease.PLoS One202642461884PubTator, text miningPubMed
First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.Diabetes Obes Metab202642396722PubTator, text miningPubMed
Lactate as a Chemical Modification on Proteins and Metabolites.Annu Rev Biochem202642331744PubTator, text miningPubMed
Targeted proteomics of extreme vascular phenotypes in type 1 diabetes: the ESCAPER study.Cardiovasc Diabetol202642323624PubTator, text miningPubMed
A direct interaction of JAM-C with the tight junction scaffold protein ZO-2.Sci Rep202642270729PubTator, text miningPubMed
In silico characterization of bioactive phytochemicals as antivirals targeting the reovirus σ1 protein for inhibiting σ1-mediated host cell entry.PLoS One202642234666PubTator, text miningPubMed
An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma.Cell Rep202642228563PubTator, text miningPubMed
Silk sericin enhances in vitro wound healing, modulates cytokeratin 16 and 17 expression, and exhibits immunomodulatory effects: an in vitro study for potential biomedical applications.Int J Biol Macromol202642208838PubTator, text miningPubMed
Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches.Cancer Biomark202642206911PubTator, text miningPubMed
Stress accelerates hepatocellular carcinoma progression via a gut microbial-metabolite axis.Front Immunol202642206057PubTator, text miningPubMed
Junctional Adhesion Molecule-A (JAM-A) Associates With High-Risk Disease in Multiple Myeloma Patients and a Structure-Based Rationally-Designed Peptide Inhibitor Attenuates Tumorigenic Features In Vitro and In Vivo.
Eur J Haematol202642204384PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/50848/papers

API referenceFor AI assistants